Showing 1 - 10 of 17
A longstanding debate on health systems organization relates to benefits of integrating health programs that emphasize specific interventions into mainstream health systems to increase access and improve health outcomes This paper is organized in five chapters. This introduction is followed by...
Persistent link: https://www.econbiz.de/10010628723
The health workforce plays a key role in increasing access to health services for the poor in developing countries. Recent evidence has demonstrated an important link between staffing levels and both service delivery and health outcomes. Various global and country-level estimates have also shown...
Persistent link: https://www.econbiz.de/10010629026
Europe is currently experiencing the fastest rate of growth of HIV of any region of the world. An analysis of policy and health system responses to the HIV epidemic in Europe and central Asia (hereafter referred to as Europe) over the last 25 years reveals considerable heterogeneity. In general,...
Persistent link: https://www.econbiz.de/10005516738
Persistent link: https://www.econbiz.de/10005516874
Persistent link: https://www.econbiz.de/10005516880
Government support for partnering between BioPharma companies and universities is growing in the UK and some European countries but few studies have explored these partnerships.Through interviews and a survey of key institutions we explored perceptions of key informants on industry and...
Persistent link: https://www.econbiz.de/10005047502
Empirical evidence demonstrates the value of intellectual property (IP) in creating economic growth, enhancing productivity and profitability, and increasing enterprise value. Research and Development (R&D) intensive industries, such as the life sciences, where patents are critical to...
Persistent link: https://www.econbiz.de/10005080978
No abstract received.
Persistent link: https://www.econbiz.de/10005050908
Multiple interacting factors influence the uptake and diffusion of medicines which are critical to improving health. However, there is a gap in our knowledge on how regulatory policies and other national health systems attributes combine to impact on the utilisation of innovative drugs, and...
Persistent link: https://www.econbiz.de/10005050909
Persistent link: https://www.econbiz.de/10005516598